Carcinoma de vejiga

GemCis en carcinoma de vejiga avanzado

- Roberts JT , von der Maase H , Sengeløv L, et al. Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer. Ann Oncol 17: v118-v122 - 2006.

Nuevos standares - 004

Imatinib adyuvante en GIST

- Dematteo RP, Ballman KV, Antonescu CR, et al, for the American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Mar 28;373(9669):1097-104

Carcinoma anal

Revisión de la literatura sobre Cáncer anal - Uronis

- Uronis HE, Bendell JC. Anal Cancer: An Overview. Oncologist 2007 12: 524-534

Cáncer de ovario

Nuevos estándares - 003

Linfoma de Hodgkin

BEACOPP es superior a AVBD en linfomas de Hodgkin de alto riesgo BEACOPP

- Massimo F, Luminari S, Iannitto E, et al. ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. J Clin Oncol 2009 27: 805-811.

Nuevos estándares - 002

Carcinoma de cérvix uterino
Quimioterapia neoadyuvante para carcinoma de cérvix uterino localmente avanzado de menos de 7 cm de diámetro, seguido por histerectomía radical

Paclitaxel + Cisplatino + Ifosfamida neoadyuvante en enfermedad localmente avanzada (Estadíos Ib, IIb de menos de 7 cm), seguida por histerectomía radical - TIP

- Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant Chemotherapy and Radical Surgery Versus Exclusive Radiotherapy in Locally Advanced Squamous Cell Cervical Cancer: Results From the Italian Multicenter Randomized Study. J Clin Oncol 2002 20: 179-188

GIST

Terapia adyuvante con Imatinib en GIST - Imatinib adyuvante en GIST

- Dematteo RP, Ballman KV, Antonescu CR, et al, for the American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Mar 28;373(9669):1097-104

Sunitinib en GIST refractario o intolerante a imatinib - Sutent_Refractory_GIST

- Demetri GD, van Oosterom AT, Garrett CR, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 2006 14 ; 368 (9544): 1329-38.